Armata Pharmaceuticals In...

AMEX: ARMP · Real-Time Price · USD
2.55
0.02 (0.79%)
At close: Aug 15, 2025, 3:56 PM
2.34
-8.24%
After-hours: Aug 15, 2025, 06:13 PM EDT

Armata Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-18.92M -69.05M -36.92M -23.16M
Depreciation & Amortization
1.32M 972K 892K 1.17M
Stock-Based Compensation
2.89M 938K 3.1M 2.88M
Other Working Capital
1.66M -9.69M -3.23M -3.41M
Other Non-Cash Items
-20.75M 29.36M 171K 60K
Deferred Income Tax
n/a n/a -171K -1.31M
Change in Working Capital
-2.1M -9.65M 439K -3.22M
Operating Cash Flow
-37.55M -47.42M -32.48M -23.57M
Capital Expenditures
-1.88M -8.14M -2.21M -1.3M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a 10K n/a n/a
Investing Cash Flow
-1.88M -8.13M -2.21M -1.3M
Debt Repayment
34.89M 54.03M n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-61K -43K -375K -801K
Financial Cash Flow
34.96M 53.99M 44.02M 25.52M
Net Cash Flow
-4.47M -1.57M 9.32M 639K
Free Cash Flow
-39.43M -55.57M -34.69M -24.88M